Medicamen Biotech Limited has informed the Exchange regarding 'Corrigendum to the Outcome of the Meeting of Board of Directors of Medicamen Biotech Limited ( the Company ) in accordance with Regulation 30 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited has submitted a corrigendum (correction) to a previously disclosed outcome of its Board of Directors meeting. The original outcome was filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. A corrigendum is issued when a company needs to rectify or update information that was previously shared with the exchange. The specific details of what is being corrected have not been disclosed in this headline. This type of filing typically follows an earlier board meeting announcement where certain financial or operational decisions were communicated.
Since this is only a corrigendum and the actual content of the correction is not provided, the immediate impact on shareholders is unclear. Investors should watch for the detailed corrigendum or the corrected board meeting outcome to understand any material changes to the previously disclosed information.